Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Venous Thromboembolism and Bleeding Risk in Patients With Esophageal Cancer

NCT03646409 is registered in ClinicalTrials.gov with Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) as lead sponsor.

NCT NCT03646409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03646409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Venous Thromboembolism and Bleeding Risk in Patients With Esophageal Cancer
Lead sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase
Observational
Overall status
Completed
Start date
June 11, 2018
Completion date
December 1, 2018
Enrollment
542 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding, chemotherapy effect, esophagus cancer, venous thromboembolism